Published in Pediatr Hematol Oncol on July 12, 1994
Familial predisposition to both male and female germ cell tumours? J Med Genet (1996) 1.12
A mini-review of familial ovarian germ cell tumors: an additional manifestation of the familial testicular germ cell tumor syndrome. Cancer Epidemiol (2009) 1.02
Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet (1987) 4.28
Water-borne outbreak of campylobacter gastroenteritis. Lancet (1983) 3.97
Investigation of a Campylobacter jejuni outbreak by serotyping and chromosomal restriction endonuclease analysis. J Clin Microbiol (1984) 3.54
Polyacrylamide gel electrophoresis of spiral bacteria from the gastric antrum. Lancet (1984) 3.52
Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med (1999) 3.03
Antigenic analysis of Campylobacter flagellar protein and other proteins. J Clin Microbiol (1985) 2.92
The identification of outer membrane proteins and flagella of Campylobacter jejuni. J Gen Microbiol (1984) 2.42
Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in patients undergoing upper gastrointestinal endoscopy. J Clin Pathol (1986) 2.38
Intestinal permeability in children with Crohn's disease and coeliac disease. Br Med J (Clin Res Ed) (1982) 2.36
Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet (1997) 2.33
Environmental isolation of heat-tolerant Campylobacter in the Southampton area. Lancet (1978) 2.12
Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc (1992) 1.99
Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group. J Clin Oncol (1993) 1.93
Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res (1997) 1.91
A retrospective study of outcome of Mohs' micrographic surgery for cutaneous squamous cell carcinoma using formalin fixed sections. Br J Dermatol (2000) 1.91
Ototoxicity of cisplatinum in children and adolescents. Br J Cancer (1990) 1.88
Mastectomy or conservation: the patient's choice. BMJ (1988) 1.83
The virulence of clinical and environmental isolates of Campylobacter jejuni. J Hyg (Lond) (1985) 1.82
Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma. Eur J Cancer (1992) 1.76
Campylobacter-associated diarrhoea in Southampton. Br Med J (1977) 1.75
Strain variation in Campylobacter pylori detected by numerical analysis of one-dimensional electrophoretic protein patterns. Antonie Van Leeuwenhoek (1989) 1.64
Primary Sjögren's syndrome in north east England--a longitudinal study. Br J Rheumatol (1991) 1.64
Lymphadenopathy in rheumatic patients. Ann Rheum Dis (1987) 1.61
The mechanism of loosening of cemented acetabular components in total hip arthroplasty. Analysis of specimens retrieved at autopsy. Clin Orthop Relat Res (1992) 1.61
Mohs' surgery of periocular basal cell carcinoma using formalin-fixed sections and delayed closure. Br J Dermatol (1998) 1.59
Demonstration of Epstein-Barr viral DNA in formalin-fixed, paraffin-embedded samples of Hodgkin's disease. J Pathol (1990) 1.56
Risk factors for ifosfamide nephrotoxicity in children. Lancet (1996) 1.56
Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl Immunol (1993) 1.55
Ifosfamide nephrotoxicity: limited influence of metabolism and mode of administration during repeated therapy in paediatrics. Eur J Cancer (1996) 1.54
Controlled release glasses (C.R.G.) for biomedical uses. Biomaterials (1981) 1.54
Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line. Cancer Res (2001) 1.52
Long-term fecal excretion and resistance induced in mice infected with Yersinia enterocolitica. Infect Immun (1978) 1.47
The need for endoscopic biopsy in the diagnosis of upper gastrointestinal graft-versus-host disease. J Pediatr Gastroenterol Nutr (1993) 1.44
Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol (1985) 1.41
Intracranial calcification in survivors of childhood medulloblastoma. Arch Dis Child (1983) 1.39
The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer. Br J Surg (1980) 1.38
Decline in incidence of medulloblastoma in children. Cancer (1994) 1.38
Case of tularaemia in England. Br Med J (1972) 1.37
Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer (1992) 1.36
The extent of surface contamination of retailed chickens with Campylobacter jejuni serogroups. Epidemiol Infect (1988) 1.32
Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992. Eur J Cancer (2000) 1.32
Incidence and survival for cancer in children and young adults in the North of England, 1968-1995: a report from the Northern Region Young Persons' Malignant Disease Registry. Br J Cancer (2000) 1.29
Cheese-borne listeria meningitis in immunocompetent patient. Lancet (1989) 1.28
Adenoid cystic carcinoma of the head and neck. Br J Plast Surg (2001) 1.25
Increase in severity of graft versus host disease by cytomegalovirus. J Clin Pathol (1992) 1.25
Local tumour invasion as a prognostic factor in colorectal cancer. Br J Surg (1981) 1.23
Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patients. Eur J Cancer (1995) 1.20
Two families with the Li-Fraumeni cancer family syndrome. J Med Genet (1982) 1.14
Hypophosphataemic rickets after ifosfamide treatment in children. BMJ (1989) 1.13
Ifosfamide, mesna, and nephrotoxicity in children. J Clin Oncol (1993) 1.13
Immunocytochemical detection of tumours of neuroectodermal origin. J Clin Pathol (1988) 1.12
Routine histological compared with immunohistological examination of bone marrow trephine biopsy specimens in disseminated neuroblastoma. J Clin Pathol (1991) 1.12
Alveolar rhabdomyosarcoma infiltrating bone marrow at presentation: the value to diagnosis of bone marrow trephine biopsy specimens. J Clin Pathol (1992) 1.11
Nephrotoxicity after ifosfamide. Arch Dis Child (1990) 1.10
p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cells. Am J Pathol (2001) 1.10
Afferent and efferent synaptic connections of somatostatin-immunoreactive neurons in the rat fascia dentata. J Comp Neurol (1990) 1.09
Giant ancient schwannoma of the pelvis. Skeletal Radiol (2000) 1.09
Pseudomembranous colitis in a colostomy. Br Med J (1978) 1.08
Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group. Med Pediatr Oncol (2001) 1.08
Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12. Eur J Clin Microbiol Infect Dis (2008) 1.08
Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy. Clin Cancer Res (2001) 1.07
1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions. European Group for Blood and Marrow Transplant Registry Solid Tumour Working Party. Eur J Cancer (1997) 1.07
Late relapse and prognosis for neuroblastoma patients surviving 5 years or more: a report from the European Neuroblastoma Study Group "Survey". Med Pediatr Oncol (2001) 1.07
Investigation of a waterborne outbreak of Campylobacter jejuni enteritis with a serotyping scheme based on thermostable antigens. J Clin Microbiol (1983) 1.06
Pharmacokinetics and metabolism of ifosfamide administered as a continuous infusion in children. Cancer Res (1993) 1.06
Improved method for immunoperoxidase detection of membrane antigens in frozen sections. J Clin Pathol (1989) 1.06
Control of rapid nitric acid decalcification. J Clin Pathol (1984) 1.05
An experimental study of the pathology and ecology of Yersinia enterocolitica infection in mice. Contrib Microbiol Immunol (1979) 1.05
Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European Osteosarcoma Intergroup study. J Clin Oncol (1999) 1.05
Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group. Br J Cancer (1990) 1.03
Histological features of skin and rectal biopsy specimens after autologous and allogeneic bone marrow transplantation. J Clin Pathol (1988) 1.02
Assessment of chemotherapy-associated nephrotoxicity in children with cancer. Cancer Chemother Pharmacol (1991) 1.02
The kinetics of the auto-induction of ifosfamide metabolism during continuous infusion. Cancer Chemother Pharmacol (1995) 1.01
Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide. Biochem Pharmacol (1994) 1.00
Phase I trials in pediatric oncology: perceptions of pediatricians from the United Kingdom Children's Cancer Study Group and the Pediatric Oncology Group. J Clin Oncol (2000) 1.00
A hospital outbreak caused by a chlorhexidine and antibiotic-resistant Proteus mirabilis. J Hosp Infect (1987) 0.99
Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies. Br J Cancer (1998) 0.99
Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group. Br J Cancer (1998) 0.99
Expression of the ErbB-neuregulin signaling network during human cerebellar development: implications for the biology of medulloblastoma. Cancer Res (1998) 0.99
Class II antigen expression by keratinocytes and enterocytes--an early feature of graft-versus-host-disease. Transplantation (1988) 0.98
Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. U.K. Children's Cancer Study Group and the U.K. Cancer Cytogenetics Group. Eur J Cancer (1997) 0.98
Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma. Exp Cell Res (2000) 0.97
Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year. J Clin Oncol (2001) 0.97
Squamous cell carcinoma of bladder. A review of 114 patients. Br J Urol (1982) 0.97
Epidermal growth factor receptor status of histological sub-types of breast cancer. Br J Cancer (1988) 0.96
Small bowel function in acute lymphoblastic leukaemia. Arch Dis Child (1984) 0.96
Globe luxation in histiocytosis X. Br J Ophthalmol (1988) 0.96
Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma. Br J Cancer (1995) 0.95
Evidence of a pattern in the variable host response to brucella in man. Lancet (1973) 0.95
Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors. J Clin Oncol (2001) 0.94